SI-BONE, Inc. Common Stock (SIBN) Stock Price
SIBNStock
$19.21+15.58%52W
Market Cap$860.96M
P/E—
PEG Ratio—
Div yield—
Beta0.67
SIBN Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)13.71%
Price vs S&P 500 (4W)2.58%
VGM Score58.04
SIBN Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | -$0.15 | -$0.09 | +39.92%(+$0.06) | |
| Q1 2026 | -$0.19 | -$0.10 | +47.76%(+$0.09) | |
| Q4 2025 | -$0.13 | -$0.04 | +68.14%(+$0.09) | |
| Q3 2025 | -$0.17 | -$0.11 | +33.33%(+$0.06) | |
| Q2 2025 | -$0.18 | -$0.14 | +21.13%(+$0.04) |
SIBN Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
4.20
4.20
4.20
4.19
Industry Peers — Surgical & Medical Instruments(140)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
SIBNSI-BONE, Inc. Common Stock | D | B | B | $19.21 |
| SYKStryker Corporation | C | B | C | $330.69 |
| MMM3M Company | C | D | C | $174.34 |
| BSXBoston Scientific Corp. | C | B | D | $46.84 |
| BDXBecton, Dickinson and Co. | B | D | B | $189.52 |
| MDLNMedline Inc. Class A common stock | C | D | C | $35.28 |
| RMDResMed Inc. | C | B | B | $240.33 |
| DXCMDexCom, Inc. | D | B | B | $90.82 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $337.47 |
| SOLVSolventum Corporation | C | C | B | $91.12 |
| BAXBaxter International Inc. | B | D | B | $26.13 |
About SI-BONE, Inc. Common Stock
SI-BONE Inc. develops and markets minimally invasive surgical implants focused on spine and orthopedic conditions, including its flagship iFuse system for sacroiliac joint fusion. The company's proprietary titanium implants and surgical instruments address high-prevalence conditions such as spinal deformity, degeneration, and pelvic trauma. With operations in the U.S. and internationally, SI-BONE serves the growing orthopedic surgery market through its specialized implant portfolio.